Kazia Therapeutics Ltd enrols first patient to phase I clinical trial of EVT801 cancer therapy

The oncology-focused drug development company licensed the investigational cancer therapy, known as EVT801, from German biotech Evotec AG in...

Related Keywords

Germany ,France ,German ,Carlos Gomez Roca ,Toulouse Oncopole Iuct ,Kazia Therapeutics Ltd ,Nasdaq ,James Garner ,L Institut Universitaire ,Cancer De Toulouse Oncopole ,Early Phase Unit ,Clinical Oncology ,